| Dr Christopher J Defrancesco, PHARMD, RPH | |
|
1800 Mulberry St, Scranton, PA 18510-2369 | |
| (570) 703-8000 | |
| Not Available |
| Full Name | Dr Christopher J Defrancesco |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1800 Mulberry St, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134353774 | NPI | - | NPPES |
| RP040736L | Other | PA | PA STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP040736L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher J Defrancesco, PHARMD, RPH 112 E Elm St, Rear, Dunmore, PA 18512-2970 Ph: () - | Dr Christopher J Defrancesco, PHARMD, RPH 1800 Mulberry St, Scranton, PA 18510-2369 Ph: (570) 703-8000 |
News Archive
Compared with biologic therapy, corticosteroid (steroid) use is associated with a nearly five-fold increase of venous thromboembolism in inflammatory bowel disease (IBD) patients, according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.
Mandatory alcohol testing programs for truck and bus drivers have contributed to a significant reduction in alcohol involvement in fatal crashes, according to a new study by researchers at the Mailman School of Public Health and the Johns Hopkins Bloomberg School of Public Health. Based on a study sample of nearly 70,000 motor carrier (heavy trucks and buses) drivers and over 83,000 non-motor-carrier (car) drivers, the estimated net effect attributed to the mandatory alcohol testing programs for drivers of heavy trucks and buses was a 23% reduced risk of alcohol involvement in fatal crashes.
University of Utah (U of U) medical researchers have uncovered a wiring diagram that shows how the brain pays attention to visual, cognitive, sensory, and motor cues. The research provides a critical foundation for the study of abnormalities in attention that can be seen in many brain disorders such as autism, schizophrenia, and attention deficit disorder.
Researchers from the Institute for Stem Cell Research and Regenerative Medicine at the University Clinic of Düsseldorf have established an in vitro model system for investigating nonalcoholic fatty liver disease (NAFLD).
Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has approved Lusedra (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.
› Verified 7 days ago
Dr. Anthony Leonard Possanza, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-8090 | |
Paul Dominick Roczniak, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Scranton Carbondale Hwy, Scranton, PA 18508 Phone: 570-489-4274 Fax: 570-489-1834 | |
Mr. Jason Michael Hapstak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1011 Scranton Carbondale Hwy, Scranton, PA 18508 Phone: 570-489-4274 Fax: 570-489-1834 | |
Samantha Tucky, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-8090 Fax: 570-703-8496 | |
Jeffrey Thomas Bachman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1777 N Keyser Ave, Scranton, PA 18508 Phone: 570-346-2087 | |
Kelly Mitchell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 609 Luzerne St, Scranton, PA 18504 Phone: 570-342-6411 | |
Nina Capitano, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 509 Davis St, Scranton, PA 18505 Phone: 570-341-3790 |